drugset / Trial / NCT06708624
Ocular Safety and Usability Study for FYB201 PFS
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study is to assess the ocular safety of the FYB201 pre-filled syringe in terms of preparation and administration by Retina Specialists in the clinical setting.
Timeline
- Start
- 2024-06-11
- Primary completion
- 2024-08-08
- Completion
- 2024-08-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |